By identifying a germline mutation of activating function, we were able to bring insight into the understanding of genetically determined upregulation of SRC activity in colorectal malignancies and to implement genetic SRC variation in familial CRC inheritance. The gene discussed is SRC; the disease is colorectal carcinoma.